June 28, 2012
Willkie Advises Loral Space in Sale of Satellite Manufacturing Unit in Deal Valued at Over $1 Billion
Loral Space & Communications Inc. agrees to sell Space Systems/Loral to Canada-based MacDonald, Dettwiler and Associates Ltd.
|
April 21, 2009
Firm Represents Stiefel Laboratories in $3.6 Billion Acquisition by GlaxoSmithKline
London-based GlaxoSmithKline plc agrees to acquire Willkie client Stiefel Laboratories Inc., the world's largest independent dermatology company.
|
October 24, 2008
Firm Represents Jupitermedia in sale of Online Images Business
Jupitermedia Corporation agrees to sell its online images business, Jupiterimages Corp., to photo and visual content distributor Getty Images, Inc. for $96 million in cash.
|
June 24, 2008
Willkie Advises Stiefel Laboratories in Acquisition of Barrier Therapeutics
Stiefel Laboratories Inc., the world's largest independent pharmaceutical company specializing in dermatology, announces agreement to acquire Barrier Therapeutics, Inc. for about $148 million.
|
September 7, 2007
Litigation Department Wins Dismissal in Industry-Wide Antitrust Case
Court dismisses significant portion of class action suit brought against dozens of insurance brokers and carriers, including Willkie client Marsh & McLennan.
|
October 24, 2006
Willkie Advises Stiefel in $930 Million Acquisition of Connetics Corp.
Stiefel Laboratories Inc. announces agreement to purchase Connetics Corporation for approximately $640 million plus the assumption of $290 million in debt.
|
January 27, 2006
Willkie Client Teva Pharmaceuticals Completes $8.5 Billion Acquisition of Ivax
Willkie client Teva Pharmaceutical Industries Ltd. announces that it has completed its acquisition of IVAX Corporation.
|
July 26, 2005
Willkie Represents Teva Pharmaceutical in $7.4 Billion Acquisition of Ivax Corp.
Teva Pharmaceutical Industries Ltd., announces agreement to acquire Ivax Corporation for approximately $7.4 billion.
|
February 22, 2005
Willkie Represents Eon Labs in $8.4 Billion Merger With Novartis and Hexal, Creating World’s Largest Generic Pharmaceutical Maker
Swiss pharmaceutical giant Novartis AG announces agreement to acquire Hexal AG of Germany and its affiliate Willkie client Eon Labs of New York for $8.4 billion in cash.
|
January 22, 2004
Firm Represents Teva Pharmaceutical Industries in $3.4 Billion Acquisition of Sicor Inc.
Willkie client Teva Pharmaceutical Industries Ltd., one of the world's largest makers of generic drugs, completes its $3.4 billion cash and stock acquisition of Sicor Inc., the Irvine, Calif.-based maker of generic sterile injectable products.
|
November 3, 2003
Willkie Represents Teva in $3.4 Billion Acquisition of Sicor
As reported in The Wall Street Journal, Willkie client Teva Pharmaceuticals Inc. purchases Irvine, Calif-based Sicor for $3.4 billion.
|
